Key Findings
- Across 9 trials (2,561 patients with cognitive impairment or dementia), standardized ginkgo (EGb761) was associated with improved cognition versus placebo (weighted mean difference −2.86 favoring ginkgo).
- Benefit was clearer at the higher 240 mg/day dose of EGb761.
- Evidence applies to people who already have cognitive impairment or dementia — not to healthy adults seeking general 'brain' support.
- Large prevention trials found ginkgo did NOT prevent dementia in healthy older adults, so it should not be used for that purpose.